Home › Myasthenia Gravis › Wisconsin
Myasthenia Gravis clinical trials in Wisconsin
7 studies for Myasthenia Gravis are looking for participants at sites in Wisconsin.
Cities in Wisconsin
A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis
- Mg0038 10108, Greenfield
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07463521A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders
- TG Therapeutics Investigational Trial Site, Milwaukee
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT06680037Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
- Site Number - 1035, Greenfield
RecruitingPhase 3
Ages 18 to 80 · All sexes · Updated Jul 30, 2026 · NCT07039916A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)
- Center for Neurological Disorders, S.C. - Greenfield - Gamma Therapeutic Center, Greenfield
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jun 18, 2026 · NCT06456580Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
- Clinical Trial Site, Milwaukee
RecruitingObservational study
Ages 18 and older · All sexes · Updated Feb 18, 2026 · NCT04202341A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa
- BCN Research, LLC - Gamma Therapeutic Center, Greenfield
RecruitingObservational study
Ages 18 and older · All sexes · Updated Feb 17, 2026 · NCT06298565Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
- Brain Inflammation Collaborative, Delafield
RecruitingObservational studyHealthy volunteers welcome
Ages 2 and older · All sexes · Updated Jan 22, 2026 · NCT04806620From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.